Bannerbild German Brest Group

Review on Endocrine Therapy in Premenopausal HR+/HER2- Metastatic Breast Cancer

06.07.2018

/wAssets/docs/forschung/2018/Tancredi_ET-in-premenopausal-HR-_HER2-metastatic-BC_-The-Oncologist.pdf

News

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd